All News about Actinium Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20240818305973/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20240809475591/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20240807905636/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/08/06/movers-image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/05/wall-street-ai9.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/05/Miscellaneous-Services.jpeg?width=1200&height=800&fit=crop)
Dow Tumbles 950 Points; ISM Services PMI Surges In July
August 05, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2024/08/05/Genetic-Research-And-Biotech-Science-Con_0.jpeg?width=1200&height=800&fit=crop)
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
August 05, 2024
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2024/08/05/wall-street-chart-shutter2.jpeg?width=1200&height=800&fit=crop)
Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
August 05, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png)
![](https://www.financialnewsmedia.com/wp-content/uploads/2020/10/ATNM.small_.jpg)
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
June 17, 2024
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1.jpg)
![](https://investorplace.com/wp-content/uploads/2023/01/meme-stock-dice-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://www.investors.com/wp-content/uploads/2024/04/TECH1_radiopharma_042624_shutter.jpg)
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
April 18, 2024
Via AB Newswire
Topics
Economy
Exposures
Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.